BeOne Medicines (ONC) Change in Account Payables (2015 - 2026)

BeOne Medicines (ONC) has reported Change in Account Payables for 12 consecutive years, with $37.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Account Payables rose 976.05% year-over-year to $37.5 million in Q2 2026; TTM through Jun 2026 was $111.0 million, a 33.04% increase from a year earlier, with the FY2025 full-year figure at $79.8 million, down 34.29% from the prior year.
• Change in Account Payables was $37.5 million for Q2 2026 at BeOne Medicines, up from -$42.2 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $108.0 million in Q4 2024 and troughed at -$44.1 million in Q2 2024.
• A 5-year average of $11.9 million and a median of $189000.0 in 2022 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 1192.5% in 2024, down 337.19% in 2024.
• Over 5 years, Change in Account Payables stood at -$8.6 million in 2022, then retreated by 15.51% to -$9.9 million in 2023, then surged by 1192.5% to $108.0 million in 2024, then decreased by 19.22% to $87.2 million in 2025, then tumbled by 56.97% to $37.5 million in 2026.
• The last three Change in Account Payables figures came in at $37.5 million (Q2 2026), -$42.2 million (Q1 2026), and $87.2 million (Q4 2025), per Business Quant data.